home / stock / vcel / vcel news


VCEL News and Press, Vericel Corporation From 08/03/22

Stock Information

Company Name: Vericel Corporation
Stock Symbol: VCEL
Market: NASDAQ
Website: vcel.com

Menu

VCEL VCEL Quote VCEL Short VCEL News VCEL Articles VCEL Message Board
Get VCEL Alerts

News, Short Squeeze, Breakout and More Instantly...

VCEL - Vericel Corporation 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Vericel Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Vericel Corporation 2022 Q2 - Results - Earnings Call Presentation

VCEL - Vericel GAAP EPS of -$0.19 misses by $0.07, revenue of $37.05M misses by $1.3M

Vericel press release ( NASDAQ: VCEL ): Q2 GAAP EPS of -$0.19 misses by $0.07 . Revenue of $37.05M (-6.3% Y/Y) misses by $1.3M . FY2022 Outlook : Total revenue guidance maintained at $178M to $189M vs. consensus of $182.19M; MACI revenue guidance maint...

VCEL - Vericel Reports Second Quarter 2022 Financial Results

Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports med...

VCEL - MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

YAVNE, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that the U.S. Food and Drug Admini...

VCEL - Vericel Q2 2022 Earnings Preview

Vericel ( NASDAQ: VCEL ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is -$0.12 (-50.0% Y/Y) and the consensus Revenue Estimate is $38.35M (-3.0% Y/Y). Over the last 2 years, VCEL has beaten EPS...

VCEL - Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

Data published in the Journal of Burn Care & Research show 83% of patients with posterior burns (mean total body surface area of 56%) had successful engraftment of Epicel after one or two applications 90% survival rate following Epicel and/or Epicel plus split thicknes...

VCEL - Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its second-quarter 2022 financial results on Wednesday, August 3, 2022. Vericel...

VCEL - Vericel (VCEL) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q1 2022 Earnings Call May 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q1 2022 Earnings Call Transcript

VCEL - Vericel Corp (VCEL) CEO Dominick Colangelo on Q1 2022 Results - Earnings Call Transcript

Vericel Corp (VCEL) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 ET Company Participants Eric Burns - Executive Director, Financial Planning and Analysis & IR Dominick Colangelo - CEO, President & Director Joseph Mara - CFO & Treasurer Conference Call Participants Ryan Zim...

VCEL - Vericel GAAP EPS of -$0.15 misses by $0.03, revenue of $36.07M beats by $1.76M

Vericel press release (NASDAQ:VCEL): Q1 GAAP EPS of -$0.15 misses by $0.03. Revenue of $36.07M (+4.3% Y/Y) beats by $1.76M. The company reaffirmed financial guidance for FY2022: Total net revenue in the range of $178M to $189M vs. consensus of $183.62M; MACI revenue expected to be in the...

Previous 10 Next 10